Rooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
The U.S. Food and Drug Administration has given approval to the metastatic breast cancer Kisqali, which was found to reduce the risk of cancer recurrence by 25%. The approval will give women diagnosed with early-stage breast cancer access to a drug to try and help prevent cancer cases from coming back. A phase III trial showed 'a significant and clinically meaningful 25.1% reduction in risk,' Novartis said in a statement.
Hospitals begin offering breakthrough radiation therapy for metastatic cancer tumorsDr. Dennis J. Slamon, a lead investigator in the trial, said 'The FDA approval of Kisqali for this early breast cancer population ... is a pivotal moment in improving our approach to care.'Novartis said around 90% of breast cancer cases in the U.S. are diagnosed in their early stages.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA expands approval of breast cancer drug Kisqali to earlier stage patientsThe FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease.
Read more »
FDA Expands Use of Breast Cancer Drug KisqaliWomen with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday.
Read more »
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage diseaseMustafa Fattah is a medical fellow with the NBC News Health and Medical Unit.
Read more »
New FDA requires women to be told about breast density in writingDoctors say by providing women details on their health in writing, it will better help them understand their risk for cancer.
Read more »
FDA requires all women to be informed about breast density, a known cancer risk factorStarting September 10th, all women will have access to what could be life-saving information about their health.
Read more »
Duke Basketball Rookie Rooted Against Blue Devils as KidKon Knueppel says he didn't become a Duke basketball fan until last season.
Read more »